US Patent Issued to Laboratory Corporation of America Holdings on Sept. 22 for "Methods and systems to detect and quantify the amount of LP-X and other abnormal lipoproteins in a biosample using NMR spectroscopy" (North Carolina, Maryland Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,792, issued on Sept. 22, was assigned to Laboratory Corporation of America Holdings (Burlington, N.C.).

"Methods and systems to detect and quantify the amount of LP-X and other abnormal lipoproteins in a biosample using NMR spectroscopy" was invented by James D. Otvos (Apex, N.C.), Irina Shalaurova (Cary, N.C.), Alan Remaley (Bethesda, Md.), Maureen Sampson (Silver Spring, Md.) and Lita Freeman (Bethesda, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are methods and systems for the determination of constituents in biosamples by NMR spectroscopy and more specifically for the determination of lipoprotein constituents LP-X, LP-Y,...